Participated · Series A · Aug 2022

Oxwash provides low‑temperature commercial and on‑demand laundry using a gentle wet‑cleaning technique with biodegradable detergents, ozone disinfection and reduced water consumption, operated from centralized hub “lagoons.” The company serves both businesses and individuals, with B2B customers including hotels, hospitals, universities, hospitality and circular fashion outlets as well as individual users. Its service is available in five UK cities and it currently operates three washing facilities; Oxwash says it has 20,000+ customers, quadrupled revenue in the past 12 months and has achieved operational profitability across its three facilities. Founded in 2017, the company recently gained B Corporation status and emphasizes employee conditions (riders and couriers are fully employed and staff are paid above the national living wage). Future plans funded by the round include building a large centralized processing facility to enable nationwide U.K. coverage, launching in the U.S. and further European expansion, and investing in next‑gen automation such as acoustic drying, robotics, computer vision and AI. Oxwash employs over 80 people and expects a 50% headcount increase in the next year, and has a stated goal of eliminating scope 1 greenhouse gas emissions from operations within 12 months. Oxwash provides a sustainable on-demand laundry service that aims to achieve net-zero carbon emissions across collection, washing and delivery. The company uses water-saving ozone technology to sterilize fabrics at lower temperatures, thermal and biodegradable chemical processes for higher-than-medical-grade disinfection, dissolvable laundry bags and electric cargo bikes for hyper-local pickups and deliveries. Founded in 2018 by ex-NASA scientist Dr Kyle Grant and Oxford engineer Tom de Wilson, Oxwash now serves more than 8,000 individual customers and enterprise clients including the Marriott Hotel Group, Hurr Collective and the NHS. Oxwash raised an additional £2.08M in seed funding, bringing total funding to £5.2M to date. The company intends to use the funds to expand the team, invest in proprietary technology and accelerate plans for national expansion. It also participated in Collective Impact, a five-week investment-readiness program delivered by Crowdcube and Virgin StartUp for purpose-led businesses. Oxwash, founded in 2017 by former NASA scientist Kyle Grant and based in London, is a sustainable on-demand laundry and dry-cleaning startup. It uses proprietary ozone-generation technology alongside thermal and chemical processes to deliver pharmaceutical-grade disinfection and aims for zero net carbon emissions across collection, washing, and delivery. Customers include consumers, hotels, gyms, and Airbnb hosts, and the company has expanded into healthcare clients such as the NHS, GP practices, care homes, vulnerable people at home, and hotels housing key workers. Oxwash provides coronavirus (COVID-19) disinfection laundry methods and is supplying services to the Oxford University coronavirus vaccine trial. The company is using the newly raised funds to launch into London, further invest in its proprietary technology platform, and expand into North America and Europe over the next 12–18 months. Its funding position is supported by a £1.75M seed round from strategic and angel investors, and an RB Ventures executive will join the board. Oxwash applies 'space-age' sterilisation technology—combining ozone disinfection with thermal and chemical processes—to deliver medical-grade laundry services that remove bacterial, fungal and viral agents. The company says its process achieves zero carbon emissions and saves water compared with traditional laundry options. A product of Oxford University and part of Founders Factory’s accelerator, Oxwash was founded by a former NASA engineer and is led by CEO Kyle Grant. It already serves business customers including Marriott and Airbnb and partners with NHS bodies, senior care homes, hotels housing medical workers, the Oxford University coronavirus vaccine trial and general practice surgeries. During the COVID-19 pandemic Oxwash added no-contact pickups, electric-cargo bikes fitted with portable ozone generators, and dissolvable laundry bags to reduce transmission. The company raised £1.4 million and says the funding will be used to grow the team, expand across southeast England, and support software development including an app and a planned roll-out to London later this year.

Participated · Series A · Jun 2021

Small Door Veterinary operates a membership-based veterinary care model that combines primary care, stress-free clinic environments, 24/7 telemedicine, and transparent pricing. The company emphasizes hospitality-grade service alongside clinical rigor to improve experiences for pets, pet parents, and medical teams. Small Door currently operates across the Northeast and Mid-Atlantic and is expanding nationally, recently opening practices in McLean, VA and Park Slope, Brooklyn. The company hired Kristen Lombardi as its first-ever Chief Operating Officer to support scaling operations. Small Door raised $55 million in new capital—$35M equity and a $20M debt facility—to fund growth, strategic new openings, and investments in member services, medical operations, and technology infrastructure. Management says it will continue growing in core markets while preparing for thoughtful, sustainable expansion. Small Door operates a membership-based, technology-powered veterinary care platform that combines in-person clinics with 24/7 telemedicine and modern facilities staffed by veterinarians trained at top programs. The company emphasizes personalized, high-engagement care and reports among the highest engagement rates in the industry measured by visit frequency and ARPU. Small Door currently operates five practices in New York City and has delivered tens of thousands of member consultations; its most mature units have generated healthy cash flow. It is a Certified B Corp and operates AAHA-accredited practices. The company plans to use new funding to expand beyond New York into Boston and Washington, D.C., opening five new locations in the first half of 2023. Funding will also support continued development of the Small Door platform. Small Door Veterinary is a New York–based membership veterinary care company that provides membership-based care, 24/7 telemedicine, and transparent pricing delivered with hospitality in spaces designed by animal experts. The company opened its first location in Manhattan’s West Village in early 2020 and will open a second practice on the Upper East Side in 2021. Co-founded by Josh Guttman and Florent Peyre, Small Door plans to expand its physical footprint to 25 locations by 2025. Small Door intends to use the funds from its recent raise to expand operations and its business reach. The company also announced that CityMD co-founder and Chief Growth Officer Nedal Shami has joined its board of directors. Financial operating metrics (revenue or user counts) were not disclosed in the article. Small Door operates a membership model that gives members a set number of annual check-ups, priority access to specialists, and virtual access to veterinarians based on membership tier. The company says the membership revenue model lets vets spend more time with each patient and reduces waiting-room wait times. Small Door was founded as a Public Benefit Corporation and emphasizes the wellbeing of vets and pets as key stakeholders. The startup plans to use new funding to further build out its team and product. It also intends to open its first Small Door clinic in New York City in the fall. The company has raised a seed round to support these expansion and product efforts.

Participated · Series E · Sep 2015

ModMed delivers specialty-specific EHRs and a suite of cloud, data, and AI-driven practice solutions, including practice management, revenue cycle management, analytics, patient engagement, payment processing, and marketing products. Its software is used by over 40,000 providers to streamline clinical workflows and improve practice efficiency. The company leverages extensive clinical data sets to design intelligent solutions that simplify, automate, and standardize clinical operations. ModMed plans to use new funding to expand operations and accelerate development efforts. Leadership includes co-CEOs Dan Cane and Joe Harpaz, and Chief Medical and Strategy Officer Dr. Michael Sherling. The article does not disclose revenue or valuation details. Modernizing Medicine builds mobile, cloud-based, specialty-specific EHR software (EMA™) used by thousands of specialty practices nationwide. Founded by Daniel Cane and Dr. Michael Sherling, the company programs products with practicing physicians to meet the unique needs of surgical and medical specialties. Its time-saving features include adaptive learning and automated outputs supported by structured data collection. The firm offers a full suite of products and services including Practice Management, Revenue Cycle Management, Telehealth for dermatology, Analytics and more. Recently the company announced a $231 million equity investment from funds affiliated with Warburg Pincus to provide liquidity, fund further expansion and support strategic initiatives. Planned initiatives include automation of prior authorization workflows, deployment of an eCommerce platform, investment in data exchange and reconciliation, and improving access to care via telemedicine. The company’s specialty EHR systems have been top-ranked by Black Book™ across multiple specialties, which the company cites as evidence of market success. Modernizing Medicine develops EMA, a cloud-based, specialty-specific electronic medical records system built by practicing physicians. EMA is available as a native iPad application and from almost any web-enabled Mac or PC and is ICD-10 ready. The company serves multiple specialties including dermatology, ophthalmology, orthopedics, otolaryngology, gastroenterology, urology and plastic surgery and is used by over 9,000 providers in the United States and its territories. Modernizing Medicine also offers specialty-specific billing and inventory management and a gastroenterology platform comprised of an EMR, Endoscopy Report Writer, practice management solution, patient portal, data analytics and revenue cycle management. The company has earned four #1 EHR Black Book Rankings for dermatology, orthopedics, otolaryngology and gastroenterology. Financially, it recently closed a $38 million Series E, bringing total capital raised to approximately $87 million. Modernizing Medicine develops the Electronic Medical Assistant (EMA), a cloud-based, specialty-specific EMR available as a native iPad application and via web-enabled Macs and PCs. EMA contains built-in specialty-specific medical knowledge and workflows, a touch-screen interface, and advanced ICD-10 capabilities, allowing charting and coding at the point of care. The company currently serves eight medical specialties and reports more than 4,000 providers have adopted EMA across more than 1,400 physician practices; in dermatology it says over 26% of U.S. dermatologists use EMA. Modernizing Medicine plans to use new funding to continue focused development in the surgical specialties and to commit resources to telemedicine, IBM Watson and mobile applications. The company expects to add approximately 100 new positions in the next 12–18 months and has received recognition such as a Leadership in Health Care Award for its co-founders and placement on Red Herring's Top 100 North America list. The company is headquartered in Boca Raton, Fla. Modernizing Medicine develops EMA™, a cloud-based, specialty-specific electronic medical record system with a large library of built-in medical content. EMA™ is available as a native iPad application or from any web-enabled Mac or PC. The company offers specialty-specific solutions for dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery. Modernizing Medicine serves more than 1,000 physician practices across the United States. Led by President and CEO Daniel Cane and based in Boca Raton, Florida, the company plans to use new funding to increase its technological staff, further grow in current markets and expand into new areas.

Led · Series A · Aug 2015

Tracksmith designs understated running apparel for traditional outdoor runners, positioning itself against the fluorescent, pattern-driven offerings of larger fitness brands. The company operates a direct-to-consumer model that it says allows experimentation with niche products and the use of fabrics larger brands do not. Its line includes items like the "run-swim-run" short and it publishes a quarterly print magazine, Meter, which it plans to launch in a digital version. Tracksmith launched as a men’s apparel brand in July of last year and debuted a women’s line in April. With the most recent influx of cash the company will continue to introduce new designs and expand its product offerings. The company raised $4.1 million in a Series A led by Pentland Group, bringing total funding to $5.7 million. Tracksmith designs and sells running apparel — singlets, racing shorts, longer casual shorts, t-shirts, and running gear bags — with a blend of modern technology and classic styling. The company was founded by Matt Taylor and Luke Scheybeler, who spent two years designing the initial product line. Taylor, a former Puma head of marketing for running and a collegiate track runner, and Scheybeler, who found success with cycling brand Rapha, position the brand as "classic American menswear meets high performance sportswear." Tracksmith’s mission is to reconnect the sport to its storied past while looking forward to its future and to celebrate running’s culture and history. The company sells direct-to-consumer via the internet and aims to form a different kind of sports brand for runners. Tracksmith may eventually expand into shoes, but is focused on apparel at launch.

Participated · Seed · May 2015

Mitoo operates a platform for sports in North America and Western Europe and is based in San Francisco, CA. It provides iOS and Android apps that let new players find sports to play and give existing players information from their leagues. The company released the newest version of its app in North America concurrent with the funding announcement. Mitoo's listings cover almost 90 percent of amateur sports leagues across basketball, softball, soccer, football, rugby, kickball and other sports. The company announced a $1.5m seed funding round from a group of investors to support its operations and product development. Named investors include White Star Capital; Slow Ventures (Dave Morin and Kevin Colleran); Tom Arrix of Lift Partners; Pentland Group; Summit Investments Worldwide; Kima Ventures; Rishi Kartaram; 500 Startups; and Andreas Koukorinis.